The FDA has had a busy 2017. In 2016 they approved only 22 novel drugs. It’s July and they’ve already approved 24.
From the first new drug to treat ALS in over two decades to new eczema treatment to several new cancer drugs, this year has seen an explosion in both orphan and nonorphan drugs. With the recent promise to start clearing all new orphan drug applications in 90 days, 2017 could see a glut of new drugs.